Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.

Συγγραφείς: Perkovic, V, Author, Barratt, J, Author, Rovin, B, Author, Kashihara, N, Author, Maes, B, Author, Zhang, H, Author, Trimarchi, H, Author, Kollins, D, Author, Papachristofi, O, Author, Jacinto-Sanders, S, Author

Συνεισφορές: Perkovic, V, Author, Barratt, J, Author, Rovin, B, Author, Kashihara, N, Author, Maes, B, Author, Zhang, H, Author, Trimarchi, H, Author, Kollins, D, Author, Papachristofi, O, Author, Jacinto-Sanders, S, Author

Πηγή: NEW ENGLAND JOURNAL OF MEDICINE. 392(6):531-543

Σύνδεσμος πρόσβασης: https://ki.se/en/research/search-research-information?t=2&query=id%3A1072104

Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial

Συγγραφείς: Perkovic, V., Trimarchi, H., Tesar, V., Lafayette, R., Wong, M.G., Barratt, J., Suzuki, Y., Liew, A., Zhang, H, Carroll, K., Jha, V., Quevedo, A., Han, S.H., Praga, M., Chacko, B., Sahay, M., Cheung, C.K., Kooienga, L., Walsh, M., Xia, J., Fajardo, C., Shah, L., Duivenvoorden, R., Hafkin, J., Rizk, D.V.

Πηγή: The New England Journal of Medicine, 394, 7, pp. 635-646

Θεματικοί όροι: Nephrology - Radboud University Medical Center

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/41211929
https://repository.ubn.ru.nl//bitstream/handle/2066/331808/331808.pdf
https://hdl.handle.net/2066/331808

Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease

Συγγραφείς: Mazhar, F, Author, Fu, EL, Author, Faucon, A-L, Author, Hjemdahl, P, Author, Mathisen, J, Author, Muhammad, IF, Author, Plunde, O, Author, Perkovic, V, Author, Tuttle, KR, Author, Carrero, J-J, Author, Mazhar, F, Author, Fu, EL, Author, Faucon, A-L, Author, Hjemdahl, P, Author, Mathisen, J, Author, Muhammad, IF, Author, Plunde, O, Author, Perkovic, V, Author, Tuttle, KR, Author, Carrero, J-J, Author

Συνεισφορές: Mazhar, F, Author, Fu, EL, Author, Faucon, A-L, Author, Hjemdahl, P, Author, Mathisen, J, Author, Muhammad, IF, Author, Plunde, O, Author, Perkovic, V, Author, Tuttle, KR, Author, Carrero, J-J, Author

Πηγή: AMERICAN JOURNAL OF KIDNEY DISEASES. 86(3):314

Σύνδεσμος πρόσβασης: https://ki.se/en/research/search-research-information?t=2&query=id%3A1030305

CroStats — visualization of population in Croatia

Συγγραφείς: Perkovic, V., Belac, F., Boros, K., Kos, M., Humski, L., Pintar, D.

Πηγή: 2023 46th MIPRO ICT and Electronics Convention (MIPRO) ICT and Electronics Convention (MIPRO), 2023 46th MIPRO. :1299-1304 May, 2023

Relation: 2023 46th MIPRO ICT and Electronics Convention (MIPRO)

Effects of anti-inflammatory agents on cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials

Συγγραφείς: Perkovic, A ^a, Webster, ER ^b, Ridker, PM ^{c, d}, Tuttle, KR ^{e, f}, Perkovic, V ^g, Neuen, BL ^{h, i, ⁎}

Πηγή: In American Journal of Preventive Cardiology June 2026 27

Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial

Συγγραφείς: Tuttle K. R., Mann J. F. E., Mayrdorfer M. M., Rayner B., Pugliese G., Pratley R. E., Perkovic V., Mahaffey K. W., Kashihara N., Jeppesen O. K., Gumprecht J., Correa-Rotter R., Cherney D. Z. I., Bosch-Traberg H., Arici M., Rossing P., Porto A., Oviedo A., Elbert A., Gelersztein E., Chertkoff A., Wassermann A., Quevedo M. A., MacIsaac R., Roger S., Phoon R., Kerr P., Ajani A., Tan S. J., Colquhoun D., Mather A., Gillard P., De Block C., Debroye C., Duyck F., Krzesinski J. M., Lapauw B., Preumont V., Vercammen C., Kamenov B. Z., Bobeva R., Levterov G., Gerilovska S., Yabrudi N., Stoyanovska-Elencheva B., Nikitov Z., Franco D., Augusto G. A., Salles J., Canani L., Krakauer M., Cerqueira M. J., Riella M., Bajaj H., Schlosser R., Ajala B., Aggarwal N., Dumas R., O'Keefe D., Peterson S., Tsoukas G., Tailor C., Tytus R., Akhras R., Khandwala H., Steen O., Carbonneau D., Cha J., Steele A., Bailey G., Berlingieri J., Dzongowski P., Cherney D., Elliott T., Kovacs C., Hamet P., Perkins B., Tennankore K., Gupta A., Ji L., Li Y., Yuan G., Dong X., Cariou B., Clavel S., Marchand L., Reznik Y., Moulin P., Legrand E., Tricaud I. B., Gourdy P., Zaoui P., Monier A., Kazes I., Dahl D., Esser M., Kruger T., Rose L., Schmieder R., Segner A., Lee-Barkey Y. H., Vidal S., Schurholz T., Boletis I., Raptis A., Lanaras L., Pagkalos E., Doupis J., Bekiari E., Goumenos D., Papadopoulou D., Tziomalos K., Karousos G., Somali M., Markou A., Zografou I., Wittmann I., Brasnyo P., Balla J., Petro G., Baranyai M., Dudas M., Vangel S., Konyves L., Vasas S., Tanczer T., Shah M., Anil B. T., Bhalla A., Gireesh M. S., Prasad N., Sahay M., Jamale T., Jain M., Magdum M., Dewan D., Dinesh K., Kumar H., Jayakumar K., Murthy S., Srikanth K., Gupta S., Aharon-Hananel G., Wainstein J., Chernin G., Kenis I., Trevisan R., Bosi E., Setola E., Fiorina P., Penno G., Giordano C., Orsi E., Cavallo M. G., Tsuchida K., Sasaki T., Seino H., Kawada T., Osonoi T., Ohashi H., Shimizu Y., Mitomo S., Nakamura C., Takai K., Maeda H., Nishi H., Nishida Y., Yamada M., Fukushima Y., Kato M., Sugawara M., Araki H., Nakagawa A., Onaka H., Sueyoshi A., Kidokoro K., Tanabe M., Jinnouchi H., Nakamura S., Hasumi S., Gonzalez-Galvez G., Salinas C. A., Morales de Teresa M., Ortiz R. M. V., Rotter J. C., Santana S. I., Lim S. K., Yoon C. K., Tan F., Goh B. L., Loh C. L., Yusoff N. S., Bax W. A., van Raalte D., Luik P. T., de Vries P. A., Dorresteijn J., AlHakim M., van Wissen S., Kamphuisen P., Verhave J., Majcher-Witczak G., Mlodawska-Choluj D., Stompor T., Ciechanowski K., Malecki R., Wasilewska K., Shamkhalova M., Ruyatkina L., Vagapova G., Sergeeva-Kondrachenko M., Kargina L., Peskov A., Zhdanova E., Lysenko T., Frolova E., Mishchenko O., Belousova L., Astamirova K., Antonova E., Pergaeva Y., Palyutin S., Sharkaeva A., Krasnopeeva N., Tyugaeva A., Krasilnikova E., Romasheva E., Sorokin M., Slovakia E., Ilavska A., Tomasova L., Porubska K., Skripova D., Buganova I., Rociakova J., Rosenberger J., Pavelcikova A., Smik R., Gorriz J., Castro C., Cigarran S., Barrios C., Soler M., Martins J., Sriwijitkamol A., Phornphutkul M., Supasyndh O., Kiattisunthorn K., Buranasupkajorn P., Susantitaphong P., Helvaci O., Ates K., Arikan I., Suleymanlar G., Yazici H., Ecder S. A., Gungor O., Ok E., Seyahi N., Eren N., Yenicerioglu Y., Chabanna O., Panina S., Semenovykh P., Leonidova V., Zinych O., Legun O., Kaydashev I., Bellary S., Boyle J., Chen M., Mcknight J., Pearson E., Philip S., Sharma S., Viljoen A., Wakeling J., Tindall H., Yousseif A., Aw T., Guerrero A., Arif A., Betts J., Busch R., Desouza C., Gonzalez-Orozco L., Dukes C., Hammoud J., Houser P., Jackson T., Kayali Z., Young L., Klein E., Lingvay I., Nicol P., Smith S., Snyder B., Soroka E., Wysham C., Akyea-Djamson A., Arauz-Pacheco C., Horeish A., Chang A., Connery L., Gandy W., Gilbert M., Hernandez G., Hewitt M., Huffman D., Lovell C., Masani N., McGill J., Siddiqui I., Perez R., Reed J., Sivalingam K., London J., Saha S., Awad A., Billings L., Blaze K., Stricklin D., Brinson C., Bornfreund J., McCall N., Buynak R., Cannon K., Daboul N., Acosta I., Diaz J., Greenwood G., Hart T., Hasan S., Iranmanesh A., Koilpillai R., Latif K., Lawrence M., Chen C., Marar I., East C., Patel R., Rovner S., Seco G., Shaikh Z., Traylor H., Zieve F., Aroda V., Ahmed A., Biscoveanu M., Budoff M., El Shahawy M., Garza J., Hanson L., Reddy J., Rodriguez H., Shrestha A., Bernardo M., Christensen T., Denker P., Dua S., Farias A., Fernando R., Jamal A., Jardula M., Moustafa M., Posada J., Sanchez W., Vega D., Kumar J., Sultan S., Bansal S., Benjamin S., Brusco O., Brusco O. A., Wayne J., Gaona R., Degani O., Figueroa C., Montero M., Rasouli N., Zemel L., Fadda G., Shlesinger Y., Charytan D., Butuk D., Stringam S., Espinosa V., Brandon D., Shea H., Cheung D., Sanchez Y., Kudva Y., Beddhu S., Bhorat Q., Badat A., Makan H., Joshi M., Basson M., Naidoo V., Amod A.

Συνεισφορές: Tuttle, K, Mann, J, Mayrdorfer, M, Rayner, B, Pugliese, G, Pratley, R, Perkovic, V, Mahaffey, K, Kashihara, N, Jeppesen, O, Gumprecht, J, Correa-Rotter, R, Cherney, D, Bosch-Traberg, H, Arici, M, Rossing, P, Porto, A, Oviedo, A, Elbert, A, Gelersztein, E, Chertkoff, A, Wassermann, A, Quevedo, M, Macisaac, R, Roger, S, Phoon, R, Kerr, P, Ajani, A, Tan, S, Colquhoun, D, Mather, A, Gillard, P, De Block, C, Debroye, C, Duyck, F, Krzesinski, J, Lapauw, B, Preumont, V, Vercammen, C, Kamenov, B, Bobeva, R, Levterov, G, Gerilovska, S, Yabrudi, N, Stoyanovska-Elencheva, B, Nikitov, Z, Franco, D, Augusto, G, Salles, J, Canani, L, Krakauer, M, Cerqueira, M, Riella, M, Bajaj, H, Schlosser, R, Ajala, B, Aggarwal, N, Dumas, R, O'Keefe, D, Peterson, S, Tsoukas, G, Tailor, C, Tytus, R, Akhras, R, Khandwala, H, Steen, O, Carbonneau, D, Cha, J, Steele, A, Bailey, G, Berlingieri, J, Dzongowski, P, Elliott, T, Kovacs, C, Hamet, P, Perkins, B, Tennankore, K, Gupta, A, Ji, L, Li, Y, Yuan, G, Dong, X, Cariou, B, Clavel, S, Marchand, L, Reznik, Y, Moulin, P, Legrand, E, Tricaud, I, Gourdy, P, Zaoui, P, Monier, A, Kazes, I, Dahl, D, Esser, M, Kruger, T, Rose, L, Schmieder, R, Segner, A

Θεματικοί όροι: CKD, clinical trial, diabete, diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonist

Περιγραφή αρχείου: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/41706532; info:eu-repo/semantics/altIdentifier/wos/WOS:001719359500001; volume:21; issue:5; firstpage:841; lastpage:851; numberofpages:11; journal:CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY; https://hdl.handle.net/10281/621282

Διαθεσιμότητα: https://hdl.handle.net/10281/621282
https://doi.org/10.2215/CJN.0000000974

Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes

Συγγραφείς: Tuttle, KR, Author, Kanbay, M, Author, Alicic, RZ, Author, Carrero, JJ, Author, Copur, S, Author, Navar, AM, Author, Neuen, BL, Author, Perkovic, V, Author, Rossing, P, Author, Marx, N, Author

Συνεισφορές: Tuttle, KR, Author, Kanbay, M, Author, Alicic, RZ, Author, Carrero, JJ, Author, Copur, S, Author, Navar, AM, Author, Neuen, BL, Author, Perkovic, V, Author, Rossing, P, Author, Marx, N, Author

Πηγή: NATURE REVIEWS NEPHROLOGY. :1-19

Σύνδεσμος πρόσβασης: https://ki.se/en/research/search-research-information?t=2&query=id%3A1144596

International Society of Nephrology International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic Health

Συγγραφείς: Pecoits-Filho, R, Banerjee, D, Jardine, MJ, Neuen, B, Soler, MJ, Ahmed, SB, Anderson, LJ, Bavanandan, S, Bansal, S, Burton, JO, Carrero, JJ, Chang, TI, Clase, CM, Cobo-Marcos, M, Manzano, AC, de Boer, IH, Greenwood, SA, Grams, ME, Herrington, WG, Heerspink, HJL, Jha, V, Kotwal, SS, Kovesdy, CP, Krishnasamy, R, Levin, A, Madero, M, Malik, C, Mathew, RO, Michos, ED, Moorthy, M, Navaneethan, SD, Perkovic, V, Rossing, P, Reusch, JEB, Robinson, BM, Sarnak, MJ, Sloan, L, Stenvinkel, P, Taal, MW, Tangri, N, Tuttle, KR, Viecelli, AK, Yee-Moon Wang, A, Wheeler, DC, Wong, MMY, Herzog, CA

Πηγή: Kidney International , 110 (4) pp. 812-828. (2026)

Θεματικοί όροι: Cardio-kidney-metabolic syndrome, cardiovascular disease, chronic kidney disease, diabetes, obesity

Περιγραφή αρχείου: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10231602/

Διαθεσιμότητα: https://discovery.ucl.ac.uk/id/eprint/10231602/1/Wheeler_1-s2.0-S0085253826006204-main.pdf
https://discovery.ucl.ac.uk/id/eprint/10231602/

Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis

Συγγραφείς: Zeng G, Bidel Z, Yang Q, Canoy D, Woodward M, Lewis J, Kjeldsen SE, Cushman WC, Yuan J, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K, Nazarzadeh M, Adler A, Agodoa L, Algra A, Anderson C, Asselbergs FW, Baigent C, Beckett NS, Berge E, Black H, Boersma E, Brenner BM, Brouwers FPJ, Brown M, Brugts JJ, Bulpitt CJ, Byington RP, Collins R, Cutler J, Devereaux RB, Dwyer JP, Estacio R, Fagard R, Fox K, Fukui T, van Gilst WH, Gupta AK, Holman RR, Imai Y, Ishii M, Julius S, Kanno Y, Kostis J, Kuramoto K, Lanke J, Lewis E, Lewis JB, Lievre M, Lindholm LH, Lubsen J, Lueders S, MacMahon S, Malacco E, Mancia G, Matsuzaki M, McManus RJ, Mehlum MH, Neal B, Nissen S, Ogawa H, Ogihara T, Ohkubo T, Palmer CR, Patel A, Perkovic V, Pfeffer MA, Pitt B, Poulter NR, Rakugi H, Reboldi G, Reid C, Remuzzi G, Rodgers A, Rothwell P, Ruggenenti P, Salimi-Khorshidi G, Saruta T, Schrader J, Schrier R, Sever P, Sleight P, Staessen JA, Sundstrom J, Suzuki H, Thijs L, Turnbull F, Ueshima K, Umemoto S, Verdecchia P, Viberti G, Wachtell K, Wang J, Whelton P, Wing L, Yui Y, Yusuf S, Zanchetti A, de Zeeuw D, Zhang Z-Y

Πηγή: The Lancet, 25 April 2026

Περιγραφή αρχείου: application/pdf

Relation: https://eprints.ncl.ac.uk/311690; https://eprints.ncl.ac.uk/fulltext.aspx?url=311690/CAE8635F-E367-4C49-8376-52BC65747830.pdf&pub_id=311690

Διαθεσιμότητα: https://eprints.ncl.ac.uk/311690

A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy

Συγγραφείς: Canney, M, Shan, S, Er, L, Billot, L, Han, J, Wong, MG, Monaghan, H, Hladunewich, M, Hooi, LS, Jha, V, Lv, J, Perkovic, V, Zhang, H, Cattran, DC, Barbour, SJ, Jha, Vivekanand

Πηγή: urn:ISSN:0085-2538 ; urn:ISSN:1523-1755 ; Kidney International, 109, 4, 738-749

Θεματικοί όροι: 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, Clinical Trials and Supportive Activities, Kidney Disease, Clinical Research, Precision Medicine, 6.1 Pharmaceuticals, Adult, Female, Humans, Male, Middle Aged, Adrenal Cortex Hormones, Glomerular Filtration Rate, Glomerulonephritis, IGA, Glucocorticoids, Methylprednisolone, Proportional Hazards Models, Time Factors, Treatment Outcome, Secondary Data Analysis, IgA nephropathy, clinical trial, corticosteroids, kidney failure, prediction, response, TESTING trial steering committee, anzsrc-for: 32 Biomedical and Clinical Sciences

Relation: https://hdl.handle.net/1959.4/107822; https://doi.org/10.1016/j.kint.2025.12.024

Διαθεσιμότητα: https://hdl.handle.net/1959.4/107822
https://doi.org/10.1016/j.kint.2025.12.024

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis: A SMART-C Collaborative Meta-Analysis

Συγγραφείς: Patel, SM, Kang, YM, Im, K, Neuen, BL, Anker, SD, Bhatt, DL, Butler, J, Cherney, DZI, Claggett, BL, Fletcher, RA, Herrington, WG, Inzucchi, SE, Jardine, MJ, Mahaffey, KW, McGuire, DK, McMurray, JJV, Neal, B, Packer, M, Perkovic, V, Solomon, SD, Staplin, N, Vaduganathan, M, Wanner, C, Wheeler, DC, Zannad, F, Zhao, Y, Heerspink, HJL, Sabatine, MS, Wiviott, SD

Πηγή: Circulation

Θεματικοί όροι: Male, Kidney Disease, Cardiac & Cardiovascular Systems, heart failure, 32 Biomedical and Clinical Sciences, Cardiovascular, anzsrc-for: 1103 Clinical Sciences, renal insufficiency, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology, Original Research Articles, Renal Insufficiency, Chronic, 3202 Clinical Sciences, anzsrc-for: 4207 Sports science and exercise, Diabetes, 3 Good Health and Well Being, 3. Good health, chronic, Heart Disease, Treatment Outcome, Cardiovascular Diseases, 6.1 Pharmaceuticals, diabetes mellitus, anzsrc-for: 3202 Clinical Sciences, Female, Life Sciences & Biomedicine, Type 2, STROKE, anzsrc-for: 1117 Public Health and Health Services, Clinical Trials and Supportive Activities, metabolic syndrome, anzsrc-for: 32 Biomedical and Clinical Sciences, Clinical Research, Diabetes Mellitus, Humans, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Heart Disease - Coronary Heart Disease, Aged, Science & Technology, EFFICACY, PREVENTION, meta-analysis, Peripheral Vascular Disease, Diabetes Mellitus, Type 2, Cardiovascular System & Cardiology, STATIN, anzsrc-for: 3201 Cardiovascular medicine and haematology, sodium-glucose cotransporter-2 inhibitors

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/38583093
https://hdl.handle.net/11370/e19bf810-c83f-4d8b-9cf5-9ab46d818159
https://doi.org/10.1161/CIRCULATIONAHA.124.069568
https://research.rug.nl/en/publications/e19bf810-c83f-4d8b-9cf5-9ab46d818159
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.069568
https://doi.org/10.1161/CIRCULATIONAHA.124.069568
https://discovery-pp.ucl.ac.uk/id/eprint/10195393/

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Συγγραφείς: Heerspink H. J. L., Agarwal R., Bakris G. L., Cherney D. Z. I., Lam C. S. P., Neuen B. L., Sarafidis P. A., Tuttle K. R., Wanner C., Brinker M. D., Dizayee S., Kolkhof P., Schloemer P., Vesterinen P., Perkovic V., Bittar J., Zaidman C. J., Cluigt N., Hominal M., Aguerre P., Halac F., Gelersztein E., Arriola M., Maldonado R., Chahin M., Packham D., Lee D., Pedagogos E., Foote C., Badve S., Hawley C., Chen J., Gray N., Speeckaert M., Labriola L., Doubel P., Maes B., Claes K., Dubois B., Dimitrova I., Vutova T., Ilchev S., Stamova S., Ivanova Y., Vasileva A., Chen X., Tang S., Xu X., Liu B., He W., He Y., Liu F., Wang C., Chen L., Niu J., Wang D., Luo P., Xia Y., Jiang G., Luo Q., Wang F., Chen M., Lin H., Yan R., Li Y., Chen Q., Dong J., Xiong F., Long H., Cheng H., Du J., Lu W., Chen C., Wang J., Liu L., Yang M., Long G., Shi Y., Li W., Yang X., Yang A., Li J., Meng X., Prazny M., Hornova L., Bucek P., Majernikova M., Wirth J., Rehorova J., Hornum M., Bech J., Lindhardt M., Hansen D., Mortensen L., Juhl C., Boletis I., Papadopoulou D., Papachristou E., Bamichas G., Petras D., Gouva C., Sarafidis P., Stylianou K., Ntounousi E., Tang S. C. W., Szeto C. C., Fung S. K. S., Lui S. L., Kovacs L., Nemeth A., Zilahi Z., Szelestei T., Kirschner R., Ignatius A., Almeida A., Sahay M., Arunkumar S., Khullar D., Pandey R., Ramanathan S., Gracious N., Mavani S., Levin-Iaina N., Rozen-Zvi B., Kruzel-Davila E., Haviv Y., Chetrit S. B., Beckerman P., Leiba A., Chernin G., Beberashvili I., Bassat O. K. -B., Kenig Y., Farber E., Ilieva A. P., Esposito C., Minutolo R., La Manna G., Santorelli G., Gregorini M. C., Donati G., Fiaccadori E., Gidaro B., Cimino R., Grandaliano G., Nakaya I., Maeda Y., Toda T., Okada H., Amemiya M., Suzuki H., Abe M., Nishi H., Kanno Y., Ueda S., Fujii T., Oshikawa J., Koizumi M., Tamura K., Yazawa M., Iwamoto T., Toyama T., Kitagawa K., Uchimura K., Kamijo Y., Ako S., Miyamoto K., Misaki T., Suzuki S., Shimizu H., Fujita Y., Ono M., Yamauchi A., Fujii H., Fujii N., Matsui M., Kidokoro K., Kanai H., Masutani K., Fujisaki K., Ishii M., Nakamura M., Toyoda M., Makita Y., Lee L. Y., Loh C. L., Yakob S., Ahmad M. K., Lee K. Q., Md Adnan W. A. H. W., Kader M. A. S. A., Ahmad N. H., Govindan S., Wahab M. Z. A., Mazlan S. A. D., Santana S. I., Wong A. C., Pardo S. A., Bayram E., Birne R., Teixeira E Costa F., Costa J. S., Alves A. R., Pereira T., Rodionova T., Antropenko N., Abissova T., Zhdanova E., Ezhov A., Suhail S. M., Liu A., Teo J., Yeo S. C., Tan N. C., Kim S., Lee K. W., Shin S. J., Han B. -G., Lee J., Han S. Y., Jang H. R., Lee J. P., Park J. T., Kang Y. S., Lee S. Y., Kim Y. C., Lee S. H., Park H., Oh J. E., Kim Y. H., Choi B. S., Segura De La Morena J. J., Jaras J. H., Deben F. M., Bouarich H., Iborra P. L., Romero M. S., Teruel J. G., Castro C., Garrit J. C., Barrios C., Chiu Y. -L., Chen H. -H., Hung C. -C., Lin S. -L., Lee C. -T., Wu M. -J., Chiu P. -F., Chang C. -T., Cheng H. -T., McCafferty K., Griffin S., Smith P., Doulton T., Pickett T., Khwaja A., Alicic R., Alla S., Anand S., Atta M., Awad A., Bansal S., Burgner A., Chang A., Christiano C., Gupta A., Hernandez G., Jamal A., Kirk E., Kopyt N., Kotzker W., Mendez R., Meyer J., Mirkhel A., Newman G., Panse S., Pergola P., Rahman M., Rastogi A., Smith M., Turner J., Umpierrez G., Vo N., Schmidt D., Frome A., Nakhoul G., Ralph R., Tolins J., Kendrick J., Quadrini M., Elahi S., Manllo S. T., Chiang W. -Y., Moussa J., Thethi T.

Συνεισφορές: Heerspink, H. J. L., Agarwal, R., Bakris, G. L., Cherney, D. Z. I., Lam, C. S. P., Neuen, B. L., Sarafidis, P. A., Tuttle, K. R., Wanner, C., Brinker, M. D., Dizayee, S., Kolkhof, P., Schloemer, P., Vesterinen, P., Perkovic, V., Bittar, J., Zaidman, C. J., Cluigt, N., Hominal, M., Aguerre, P., Halac, F., Gelersztein, E., Arriola, M., Maldonado, R., Chahin, M., Packham, D., Lee, D., Pedagogos, E., Foote, C., Badve, S., Hawley, C., Chen, J., Gray, N., Speeckaert, M., Labriola, L., Doubel, P., Maes, B., Claes, K., Dubois, B., Dimitrova, I., Vutova, T., Ilchev, S., Stamova, S., Ivanova, Y., Vasileva, A., Chen, X., Tang, S., Xu, X., Liu, B., He, W., He, Y., Liu, F., Wang, C., Chen, L., Niu, J., Wang, D., Luo, P., Xia, Y., Jiang, G., Luo, Q., Wang, F., Chen, M., Lin, H., Yan, R., Li, Y., Chen, Q., Dong, J., Xiong, F., Long, H., Cheng, H., Du, J., Lu, W., Chen, C., Wang, J., Liu, L., Yang, M., Long, G., Shi, Y., Li, W., Yang, X., Yang, A., Li, J., Meng, X., Prazny, M., Hornova, L., Bucek, P., Majernikova, M., Wirth, J., Rehorova, J., Hornum, M., Bech, J., Lindhardt, M., Hansen, D., Mortensen, L., Juhl, C., Boletis, I., Papadopoulou, D.

Θεματικοί όροι: clinical trial, eGFR slope, finerenone, immunoglobulin A nephropathy, non-diabetic chronic kidney disease

Περιγραφή αρχείου: ELETTRONICO

Relation: info:eu-repo/semantics/altIdentifier/pmid/38858818; info:eu-repo/semantics/altIdentifier/wos/WOS:001287525900001; volume:40; issue:2; firstpage:308; lastpage:319; numberofpages:12; journal:NEPHROLOGY DIALYSIS TRANSPLANTATION; https://hdl.handle.net/11585/1018002; https://academic.oup.com/ndt/article/40/2/308/7690802

Διαθεσιμότητα: https://hdl.handle.net/11585/1018002
https://doi.org/10.1093/ndt/gfae132
https://academic.oup.com/ndt/article/40/2/308/7690802

Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

Συγγραφείς: Sarraju, A, Bakris, G, Cannon, CP, Cherney, D, Damaraju, CV, Figtree, GA, Gogate, J, Greene, T, Heerspink, HJL, Januzzi, JL, Neal, B, Jardine, MJ, Blais, J, Kosiborod, M, Levin, A, Lingvay, I, Weir, MR, Perkovic, V, Mahaffey, KW

Πηγή: Journal of the American College of Cardiology. 80:1721-1731

Θεματικοί όροι: Adult, Male, Kidney Disease, Clinical Trials and Supportive Activities, heart failure, 32 Biomedical and Clinical Sciences, Cardiovascular, Kidney, 03 medical and health sciences, anzsrc-for: 32 Biomedical and Clinical Sciences, 0302 clinical medicine, Clinical Research, anzsrc-for: 1102 Cardiorespiratory Medicine and Haematology, Diabetes Mellitus, Humans, Albuminuria, Diabetic Nephropathies, Canagliflozin, canagliflozin, 3202 Clinical Sciences, Sodium-Glucose Transporter 2 Inhibitors, Heart Failure, diabetes, Prevention, Diabetes, 3 Good Health and Well Being, SGLT2 inhibitor, Middle Aged, 16. Peace & justice, cardiovascular outcomes, 3. Good health, Health Disparities, Heart Disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases, anzsrc-for: 3202 Clinical Sciences, Female, Type 2, anzsrc-for: 1117 Public Health and Health Services, anzsrc-for: 3201 Cardiovascular medicine and haematology, Glomerular Filtration Rate

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/36302584
https://research.rug.nl/en/publications/8045b6da-c7c7-411e-bf62-33bf2b80b3c9
https://hdl.handle.net/11370/8045b6da-c7c7-411e-bf62-33bf2b80b3c9
https://doi.org/10.1016/j.jacc.2022.08.772

Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials

Συγγραφείς: Chatur, S, Vaduganathan, M, Fletcher, RA, Perkovic, V, Heerspink, H, Arnott, C, Pollock, C, Mahaffey, KW, Neal, B, Jardine, M, Solomon, SD, Neuen, BL

Πηγή: urn:ISSN:1388-9842 ; urn:ISSN:1879-0844 ; European Journal of Heart Failure, 27, 6, 994-1002

Θεματικοί όροι: 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, Heart Disease, Kidney Disease, Clinical Research, Clinical Trials and Supportive Activities, Cardiovascular, Diabetes, 6.1 Pharmaceuticals, Aged, Female, Humans, Male, Middle Aged, Administration, Oral, Canagliflozin, Diabetes Mellitus, Type 2, Disease Progression, Follow-Up Studies, Heart Failure, Hospitalization, Renal Insufficiency, Chronic, Sodium Potassium Chloride Symporter Inhibitors, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, Chronic kidney disease, Loop diuretic

Περιγραφή αρχείου: application/pdf

Relation: https://hdl.handle.net/1959.4/104401; https://doi.org/10.1002/ejhf.3586

Διαθεσιμότητα: https://hdl.handle.net/1959.4/104401
https://unsworks.unsw.edu.au/bitstreams/41488de0-42be-4b5a-807a-6fe44622976d/download
https://doi.org/10.1002/ejhf.3586

Canagliflozin and iron metabolism in the CREDENCE trial

Συγγραφείς: Koshino, A, Heerspink, HJL, Jongs, N, Badve, SV, Arnott, C, Neal, B, Jardine, M, Mahaffey, KW, Pollock, C, Perkovic, V, Hansen, MK, Bakker, SJL, Wada, T, Neuen, BL

Πηγή: urn:ISSN:0931-0509 ; urn:ISSN:1460-2385 ; Nephrology Dialysis Transplantation, 40, 4, 696-706

Θεματικοί όροι: 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, Clinical Trials and Supportive Activities, Cardiovascular, Diabetes, Hematology, Clinical Research, Kidney Disease, Dietary Supplements, Nutrition, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Renal and urogenital, 3 Good Health and Well Being, Humans, Male, Canagliflozin, Female, Middle Aged, Iron, Renal Insufficiency, Chronic, Aged, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Double-Blind Method, Follow-Up Studies, Prognosis, Glomerular Filtration Rate

Περιγραφή αρχείου: application/pdf

Relation: https://hdl.handle.net/1959.4/104434; https://doi.org/10.1093/ndt/gfae198

Διαθεσιμότητα: https://hdl.handle.net/1959.4/104434
https://unsworks.unsw.edu.au/bitstreams/938a192a-8a6c-42ac-9bd6-9005506bb034/download
https://doi.org/10.1093/ndt/gfae198

SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria: a meta-analysis

Συγγραφείς: Neuen, BL, Fletcher, RA, Anker, SD, Bhatt, DL, Butler, J, Cherney, DZI, Docherty, KF, Inzucchi, SE, Jardine, MJ, Mahaffey, KW, McCausland, FR, McGuire, DK, McMurray, JJV, Neal, B, Packer, M, Patel, SM, Perkovic, V, Sabatine, MS, Sardell, RJ, Solomon, SD, Vaduganathan, M, Wanner, C, Wheeler, DC, Zannad, F, Haynes, R, Staplin, N, Heerspink, HJL, Herrington, WG

Συνεισφορές: (SMART-C), SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists’ Consortium

Relation: https://doi.org/10.1001/jama.2025.20834

Διαθεσιμότητα: https://doi.org/10.1001/jama.2025.20834
https://ora.ox.ac.uk/objects/uuid:2c693646-003c-4b13-9bc9-8872594b632c

Sodium-Glucose Cotransporter 2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials

Συγγραφείς: Oshima, M, Buizen, L, Jongs, N, Levin, A, Chertow, GM, Wheeler, DC, Heerspink, HJL, Arnott, C, Jardine, MJ, Mahaffey, KW, Pollock, C, Herrington, WG, Perkovic, V, Neuen, BL

Πηγή: Clinical Journal of the American Society of Nephrology , 20 (9) pp. 1206-1214. (2025)

Περιγραφή αρχείου: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10211921/

Διαθεσιμότητα: https://discovery.ucl.ac.uk/id/eprint/10211921/3/Wheeler_CJASN%20all-cause%20hospitalization%20R1%20clean%2020250502.pdf
https://discovery.ucl.ac.uk/id/eprint/10211921/

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis

Συγγραφείς: Staplin, N, Roddick, AJ, Neuen, BL, Anker, SD, Bhatt, DL, Butler, J, Cherney, DZ, Docherty, KF, Fletcher, RA, Inzucchi, SE, Jardine, M, Mahaffey, KW, Mcguire, DK, Mcmurray, JJV, Neal, B, Packer, M, Patel, SM, Perkovic, V, Sabatine, MS, Solomon, S, Vaduganathan, M, Wanner, C, Wheeler, DC, Zannad, F, Haynes, R, Heerspink, HJL, Herrington, WG

Πηγή: Journal of the American Medical Association (2025) (In press).

Θεματικοί όροι: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine

Περιγραφή αρχείου: application/pdf

Relation: https://discovery.ucl.ac.uk/id/eprint/10219805/

Διαθεσιμότητα: https://discovery.ucl.ac.uk/id/eprint/10219805/1/Wheeler_SMART-C%20meta%20analysis%20eGFR%20albuminuria_merged_1759512634.pdf
https://discovery.ucl.ac.uk/id/eprint/10219805/

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

Συγγραφείς: Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K, Agodoa L, Algra A, Asselbergs FW, Beckett N, Berge E, Black H, Brouwers FPJ, Brown M, Bulpitt CJ, Byington B, Cutler J, Devereaux RB, Dwyer J, Estacio R, Fagard R, Fox K, Fukui T, Imai Y, Ishii M, Julius S, Kanno Y, Kjeldsen SE, Kostis J, Kuramoto K, Lanke J, Lewis E, Lewis J, Lievre M, Lindholm LH, Lueders S, MacMahon S, Mancia G, Matsuzaki M, Mehlum MH, Nissen S, Ogawa H, Ogihara T, Ohkubo T, Palmer C, Patel A, Pfeffer M, Poulter NR, Rakugi H, Reboldi G, Reid C, Remuzzi G, Ruggenenti P, Saruta T, Schrader J, Schrier R, Sever P, Sleight P, Staessen JA, Suzuki H, Thijs L, Ueshima K, Umemoto S, van Gilst WH, Verdecchia P, Wachtell K, Whelton P, Wing L, Yui Y, Yusuf S, Zanchetti A, Zhang ZY, Anderson C, Baigent C, Brenner BM, Collins R, de Zeeuw D, Lubsen J, Malacco E, Neal B, Perkovic V, Pitt B, Rodgers A, Rothwell P, Salimi-Khorshidi G, Sundstrom J, Turnbull F, Viberti G, Wang J

Συνεισφορές: Collaboration, Blood Pressure Lowering Treatment Trialists'

Πηγή: Lancet Diabetes Endocrinol
Nazarzadeh, M, Bidel, Z, Canoy, D, Copland, E, Bennett, D A, Dehghan, A, Davey Smith, G, Holman, R R, Woodward, M, Gupta, A, Adler, A I, Wamil, M, Sattar, N, Cushman, W C, McManus, R J, Koon, T, Davis, B R, Chalmers, J, Pepine, C J & Rahimi, K 2022, 'Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes : an individual participant-level data meta-analysis', Lancet Diabetes and Endocrinology, vol. 10, no. 9, pp. 645-654. https://doi.org/10.1016/S2213-8587(22)00172-3

Θεματικοί όροι: Male, 32 Biomedical and Clinical Sciences, Blood Pressure, Cardiovascular, anzsrc-for: 1103 Clinical Sciences, anzsrc-for: 3205 Medical Biochemistry and Metabolomics, 1117 Public Health and Health Services, anzsrc-for: 32 Biomedical and Clinical Sciences, Diabetes Mellitus, Humans, Minority Health, 3202 Clinical Sciences, anzsrc-for: 1101 Medical Biochemistry and Metabolomics, Antihypertensive Agents, Heart Failure, 3205 Medical Biochemistry and Metabolomics, Diabetes, 3 Good Health and Well Being, 1103 Clinical Sciences, Articles, 16. Peace & justice, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Hypertension, 3. Good health, Heart Disease, 1101 Medical Biochemistry and Metabolomics, 6.1 Pharmaceuticals, name=Bristol Population Health Science Institute, Blood Pressure Lowering Treatment Trialists' Collaboration, anzsrc-for: 3202 Clinical Sciences, Type 2, anzsrc-for: 1117 Public Health and Health Services

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/35878651
https://ora.ox.ac.uk/objects/uuid:291a6115-e1bb-4050-9b7c-a387a9a3ac96
https://doi.org/10.1016/s2213-8587(22)00172-3
https://hdl.handle.net/10281/432638
https://doi.org/10.1016/S2213-8587(22)00172-3
https://research-information.bris.ac.uk/en/publications/84ee6f6a-4a1b-40c1-b7fd-ddad7d9cf34d
https://hdl.handle.net/1983/84ee6f6a-4a1b-40c1-b7fd-ddad7d9cf34d
https://doi.org/10.1016/S2213-8587(22)00172-3
https://research-information.bris.ac.uk/ws/files/338562501/PIIS2213858722001723.pdf

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis

Συγγραφείς: Li, C, Yu, J, Hockham, C, Perkovic, V, Neuen, BL, Badve, SV, Houston, L, Lee, VYJ, Barraclough, JY, Fletcher, RA, Mahaffey, KW, Heerspink, HJL, Cannon, CP, Neal, B, Arnott, C

Πηγή: Diabetes, Obesity and Metabolism. 24:1927-1938

Θεματικοί όροι: Kidney Disease, Clinical Trials and Supportive Activities, RATIONALE, 32 Biomedical and Clinical Sciences, Cardiovascular, anzsrc-for: 1103 Clinical Sciences, MECHANISMS, Brain Ischemia, 03 medical and health sciences, anzsrc-for: 32 Biomedical and Clinical Sciences, KIDNEY, 0302 clinical medicine, DESIGN, Sodium-Glucose Transporter 2, Clinical Research, BASE-LINE CHARACTERISTICS, Atrial Fibrillation, Diabetes Mellitus, Humans, COTRANSPORTER 2 INHIBITORS, CARDIOVASCULAR ASSESSMENT, Canagliflozin, 3202 Clinical Sciences, RISK, OUTCOMES, Diabetes, 3. Good health, Stroke, Heart Disease, Atrial Flutter, Diabetes Mellitus, Type 2, 6.1 Pharmaceuticals, anzsrc-for: 3202 Clinical Sciences, Type 2

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/35589614
https://research.rug.nl/en/publications/d3ad4268-ca54-4aeb-ae3f-21ee6b19c1b9
https://hdl.handle.net/11370/d3ad4268-ca54-4aeb-ae3f-21ee6b19c1b9
https://doi.org/10.1111/dom.14772